Modular Cognitive Behavioral Therapy for the Treatment of Child Anxiety Disorders in Elementary School Settings
KATES
A Randomized, Controlled Trial of Modular CBT for Child Anxiety Disorders in Elementary School Settings
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Although cognitive behavioral therapy (CBT) has been found to be efficacious in the treatment of child anxiety disorders, little progress has been made in the dissemination of such treatments to real-world practice settings. Clinical trials conducted in practice settings can demonstrate the degree to which evidence-based treatments are appropriate for larger scale dissemination. This study evaluates CBT as a treatment for child anxiety disorders in the elementary school clinic setting. A randomized, controlled trial design has been employed, comparing immediate treatment and a three-month waitlist. The trial is being conducted in several Los Angeles area elementary schools and is only available to children in these particular schools. To ensure that the CBT intervention is flexible and capable of matching the characteristics of various school settings, clinicians, and referred children, a modular treatment approach is employed. The study design includes elements to ensure high quality data, such as the use of independent evaluators and tests of treatment fidelity. Children, ages 5 to 12 years, are referred by teachers and staff or are identified as having high anxiety in concurrent studies. All participating children have DSM-IV diagnoses of separation anxiety disorder, generalized anxiety disorder, or social phobia, according to a semi-structured diagnostic interview. Therapy and clinical supervision is provided by the research team. It is hypothesized that children receiving immediate treatment will have significantly lower anxiety scores than children assigned to the waitlist at the posttreatment/postwaitlist assessment. If results are favorable, further exploration of dissemination of CBT into school clinic settings may be indicated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jan 2004
Longer than P75 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedFirst Submitted
Initial submission to the registry
December 5, 2007
CompletedFirst Posted
Study publicly available on registry
December 7, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedMarch 30, 2012
March 1, 2012
4.4 years
December 5, 2007
March 28, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinician's Global Impressions-Improvement (CGI) scale
Posttreatment / postwaitlist
Secondary Outcomes (1)
Anxiety Disorders Interview Schedule IV: Child and Parent Version
Posttreatment / postwaitlist
Study Arms (2)
1
EXPERIMENTALCognitive behavioral therapy
2
NO INTERVENTIONWaitlist
Interventions
1 to 16 weekly sessions of modular cognitive behavioral therapy, each lasting 60-80 minutes
Eligibility Criteria
You may qualify if:
- The child meets DSM-IV criteria for separation anxiety disorder (SAD), social phobia, or generalized anxiety disorder (GAD) based on a diagnostic interview
- The child is not taking any psychiatric medication at the initial assessment, or is taking a stable dose of psychiatric medication (i.e., at least one month at a stable dose prior to the baseline assessment)
- If medication is being used, children will maintain that dose throughout the study
You may not qualify if:
- The child is currently in psychotherapy
- The family is currently in family therapy or a parenting class
- The child begins taking psychiatric medication or increases his/her dose of medication during the intervention
- For any reason the child or parents appear unable to participate in the intervention program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey J Wood, PhD
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 5, 2007
First Posted
December 7, 2007
Study Start
January 1, 2004
Primary Completion
June 1, 2008
Study Completion
June 1, 2009
Last Updated
March 30, 2012
Record last verified: 2012-03